19:18 , Mar 2, 2017 |  BC Innovations  |  Translation in Brief

Polyester protection

A vaccine based on engineered biobeads offers a new paradigm for immunization against tuberculosis that incorporates both known and unknown antigens to mimic the broad repertoire of live vaccines, but with the safety of non-infectious...
07:00 , Jun 10, 2013 |  BC Week In Review  |  Company News

Bill & Melinda Gates Foundation infectious news

The Bill & Melinda Gates Foundation awarded $8.1 million in grants under Round 10 of its Grand Challenges Explorations (GCE) initiative. The foundation awarded 58 new $100,000 grants for global health and development proposals, as...
08:00 , Mar 2, 2009 |  BC Week In Review  |  Company News

GTC Biotherapeutics, AgResearch, Dong-A Pharmaceutical deal

GTC and AgResearch will develop transgenic goats to produce two biosimilar mAbs of undisclosed marketed drugs. GTC said the deal is part of its long term biosimilar strategy and will enable earlier sales of the...
08:00 , Feb 20, 2006 |  BioCentury  |  Strategy

A near death experience

Four years ago, with barely E1 million in the bank, Pharming Group N.V. was forced into receivership, having bitten off more than it could chew trying to develop alpha glucosidase to treat Pompe's disease in...
08:00 , Feb 20, 2006 |  BioCentury  |  Strategy

Pharming chronicles

Pharming chronicles Selected events tracked against Pharming's daily stock price since the company listed on Euronext in 1999. Y-axis = Price per share on log scale 7/2/98 - Raises $70.9M in IPO and lists on...
07:00 , Jul 4, 2005 |  BC Week In Review  |  Company News

AgResearch Ltd., Pharming deal

AgResearch will produce PHARM's recombinant human lactoferrin and will provide access to its purification services. PHARM granted AgResearch a license to its recombinant protein production technology. In return, PHAR will have the first right to...
08:00 , Mar 21, 2005 |  BioCentury  |  Finance

Ebb & Flow

Phase III Avastin data always seem to be good for an $11 billion pop in Genentech's market cap, and the company is two for two on that front. Such was the case in 2003, when...
07:00 , Aug 13, 2001 |  BC Week In Review  |  Company News

AgResearch Ltd., Clone International Pty. Ltd., Geron deal

AgResearch and Clone, as partners, received an exclusive license to use GERN’s nuclear transfer technology in New Zealand and Australia in exchange for a 25% equity interest for GERN in Clone and a share of...
08:00 , Dec 18, 2000 |  BC Week In Review  |  Company News

PPL, Celentis deal

PTH entered into a 50-50 joint venture with Celentis, the commercial arm of AgResearch, a New Zealand government research institute. The companies will produce pharmaceutical and nutraceutical proteins in the milk of transgenic cattle, initially...
08:00 , Dec 18, 2000 |  BioCentury  |  Finance

Meltdown

After suffering a regulatory and investor thrashing that knocked 70 percent off the company's value last week, Maxim's market cap of $185.9 million now stands below the $190.4 million in cash it had on the...